¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"copper sulfate method"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • cup cylinder method
    ¿øÅë¹ý
  • chain termination method
    »ç½½Á¾·á¹ý, ¿¬¼âÁ¾·á¹ý
  • checkerboard method
    ¹ÙµÏÆÇ¹æ¹ý
  • dye dilution method
    »ö¼ÒÈñ¼®¹ý
  • dilution egg counting method
    Èñ¼®Ãæ¶õ°è»ê¹ý
  • disc method
    ¿ø¹Ý¹ý, ¿ø¹ÝÈ®»ê¹ý
  • distribution-free method
    ºñºÐÆ÷¹æ¹ý
  • double blind method
    ÀÌÁ߸Ͱ˹ý, °ã´«°¡¸²¹ý
  • double investing method
    ÀÌÁ߸Ÿô¹ý
  • exact method
    Á÷Á¢È®·ü¹ý
  • exclusion method
    ¹èÁ¦¹æ¹ý
  • expansion method
    ÆØÃ¢¹æ¹ý
  • electronic method
    ÀüÀÚ¹æ¹ý
  • elution method
    ¿ëÃâ¹ý
  • ether centrifugal sedimentation method
    ¿¡Å׸£¿ø½ÉħÀü¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • convergent method
    ¼ö·ÅÁ¶»ç¹ý
  • cough plate method
    ±âħÆòÆÇ¹ý
  • cup cylinder method
    ¿øÅë¹ý
  • detector tube method
    °ËÁö°ü¹ý
  • dilution egg counting method
    Èñ¼®Ãæ¶õ°è»ê¹ý
  • disc method
    ¿øÆÇ¹ý, ¿øÆÇÈ®»ê¹ý, µð½ºÅ©È®»ê¹ý
  • distribution-free method
    ºñºÐÆ÷¹æ¹ý
  • double blind method
    ÀÌÁ߸Ͱ˹ý
  • double investing method
    ÀÌÁ߸Ÿô¹ý
  • dye dilution method
    »ö¼ÒÈñ¼®¹ý
  • electric impedance method
    Àü±âÀå¾Ö¹ý
  • electronic method
    ÀüÀÚÀû¹æ¹ý
  • elution method
    ¿ëÃâ¹ý
  • ether centrifugal sedimentation method
    ¿¡Å׸£¿ø½ÉħÀü¹ý
  • everted sac method
    µÚÁýÈùÀå°ü³¶¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • acquisition method
    ȹµæ ¹æ¹ý
  • activated sludge method
    Ȱ¼º¿À´Ï¹ý(Ì·ËÛËçËöËÑ).
  • actuarial method
    º¸ÇèÅë°è¹ý
  • agar diffusion method
    ÇÑõ(³»)È®»ê¹ý.
  • agar filtration method
    ÇÑõ°Å¸£±â(¹ý), ÇÑõ¿©°ú¹ý.
  • agar layer method
    ÇÑõÁßÃþ¹ý(¡­ñìöµÛö).
  • agar streak method
    ÇÑõȭ¼±¹ý(¡­ûþàÊÛö).
  • albumin method
    ¾ËºÎ¹Î¹ý
  • allochromatic method
    º¯»ö¹ý.
  • alternate case method
    ±³´ëȯÀÚ¿ä¹ý.
  • alternate paired case method
    ±³´ë´ë¸³È¯ÀÚ¿ä¹ý(ÎßÓÛÓßí¡ü´íºèþÛö).
  • analytical method
    ºÐ¼®¹ý
  • gasometric method
    °¡½ºÁ¤·®¹ý.
  • gradient method
    °è´ÜÀû°Ë»ç¹ý
  • graphic method
    ±×·¡ÇÁ¹ý, ¼±µµ¹ý(ËÛËÀËÑ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • activated sludge method
    Ȱ¼º¿À´Ï¹ý(Ì·ËÛËçËöËÑ).
  • actuarial method
    º¸ÇèÅë°è¹ý
  • agar diffusion method
    ÇÑõ(³»)È®»ê¹ý.
  • agar filtration method
    ÇÑõ°Å¸£±â(¹ý), ÇÑõ¿©°ú¹ý.
  • agar layer method
    ÇÑõÁßÃþ¹ý(¡­ñìöµÛö).
  • agar streak method
    ÇÑõȭ¼±¹ý(¡­ûþàÊÛö).
  • albumin method
    ¾ËºÎ¹Î¹ý
  • alkaline phosphatase antialkaline phophatase method
    ¾ËÄ®¸®¼º Æ÷½ºÆÄŸÁ¦ Ç×¾ËÄ®¸®¼º Æ÷½ºÆÄŸÁ¦¹ý
  • allochromatic method
    º¯»ö¹ý.
  • alternate case method
    ±³´ëȯÀÚ¿ä¹ý.
  • alternate paired case method
    ±³´ë´ë¸³È¯ÀÚ¿ä¹ý(ÎßÓÛÓßí¡ü´íºèþÛö).
  • analytical method
    ºÐ¼®¹ý
  • ascending method
    »ó½Â¹ý
  • aspirative irrigation method
    ÈíÀμ¼Ã´¹ý.
  • auscultatory method
    ûÁø¹ý.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Folin method
    Æú¸°¹ý(Ûö)
  • Folin-Wu method
    Æú¸°-¿ì¹ý(Ûö)
  • gaseous exposure method
    °³½º ³ëÃâ¹ý(ÖÚõóÛö)
  • Gilbert-Maxam method
    ±æ¹öÆ®-¸Æ»ï¹ý(Ûö)
  • gradient-flow method
    ±¸¹è(ÎþÛÕ)-È帧¹ý(Ûö)
  • heavy atom method
    Áß¿øÀÚ¹ý(ñìê«í­Ûö)
  • high-temperature-short-time method
    °í¿Â ´Ü½Ã°£¹ý(ÍÔè®Ó­ãÁÊàÛö)
  • isotope derivative method
    µ¿À§¿ø¼ÒÀ¯µµÃ¼¹ý(ÔÒêÈêªáÈë¯Óôô÷Ûö)
  • jump method
    ¶Ù±â ¹æ¹ý(Û°Ûö)
  • Kjeldahl method
    Ű¿¤´Þ¹ý(Ûö)
  • label triangulation method
    Ç¥Áö»ï°¢È­¹ý(øöò½ß²ÊÇûùÛö)
  • Lowry method
    ·Î¿ì¸®¹ý(Ûö)
  • low-temperature heat method
    Àú¿Â¿­¹ý(î¸è®æðÛö)
  • LTH method
    LTH¹ý(Ûö)
  • matrix method
    ¸ÅÆ®¸¯½º¹ý(Ûö)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
BPN bacitracin, polymyxin B, neomycin sulfate; brachial plexus neuropathy
CHS central hypoventilation syndrome; Chediak-Higashi syndrome; cholinesterase; chondroitin sulfate; com...
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
C4S chondroitin-4-sulfate
CSA Canadian Standards Association; canavaninosuccinic acid; carbonyl salicylamide; cell surface antigen...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
MDL method detection limit
D.C.C. dextran coated charcoal method
PAP peroxidase anti peroxidase method
PCR polimerase chain reaction method
SCAM substituted cysteine accessibility method
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • double investing method
    ÀÌÁß ¸Å¸ô¹ý
  • draining method
    ¹è³ó¹ý, È긮´Â ¹æ¹ý
    »óó, ±Ë¾ç, °øµ¿¿¡¼­ ¾×ü³ª ¹è¼³¹°À» ü°èÀûÀ¸·Î ¹èÃâ½ÃŰ´Â °Í.
  • dye dilution method
    »ö¼Ò Èñ¼®¹ý
  • electromyogram biofeedback method
    ±ÙÀüµµ ¹ÙÀÌ¿ÀÇǵå¹é¹ý
    ¹ÙÀÌ¿ÀÆÐµå¹éÀÇ ÁöÇ¥·Î ±ÙÀüµµ¸¦ »ç¿ëÇÏ´Â °ÍÀÌ°í ±Ù·Â Áõ°­ ÈÆ·Ã°ú ±Ù ÀÌ¿Ï ÈÆ·Ã°ú´Â ÀüÇô ¹Ý´ëÀÇ Ä¡·á¹ýÀ¸·Î ÇÔ²² ÀÌ¿ëµÈ´Ù. ±Ù·Â Áõ°­ ÈÆ·ÃÀ¸·Î¼­´Â ¸»ÃÊ½Å°æ ¸¶ºñ, ³úÁ¹Áß, ³ú¼º ¸¶ºñ µî¿¡ »ç¿ëµÇ°í ±ÙÀÌ¿Ï ÈÆ·ÃÀ¸·Î¼­´Â »ç°æ µî¿¡ »ç¿ëµÈ´Ù.
  • expansion method
    ÆØÃ¢ ¹æ¹ý
    ¸Å¸ôÀçÀÇ °æÈ­ ÆØÃ¢, °¡¿­ ÆØÃ¢À» ÀÌ¿ëÇϰųª ¸ðÇü Àç·áÀÇ °æÈ­ ÆØÃ¢À» ÀÌ¿ëÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • fast gradient recalled echo method
    °í¼Ó °æ»ç ȸº¹ ¿¡ÄÚ ±â¹ý
  • flash method
    ¿ìÀ¯ ¼Òµ¶¹ý
    ¿ìÀ¯¸¦ 80¡É±îÁö ±Þ¼ÓÈ÷ °¡¿­ÇÑ ÈÄ¿¡ ±Þ¼ÓÈ÷ 5¡É·Î ³»¸®´Â ¸ê±Õ¹ý.
  • functional jaw orthopedic method
    ±â´ÉÀû ¾Ç±³Á¤¹ý
  • immunofluorescence method
    ¸é¿ª Çü±¤¹ý
    Ç×ü³ª Ç׿ø¿¡ Ç÷ç¿À·¹¼¼ÀÎÀ̳ª ·Î´Ù¹Î°ú °°Àº Çü±¤ »ö¼Ò¸¦ Ç¥ÁöÇÑ °ÍÀ» »ç¿ëÇÏ¿© ü¾×°ú Á¶Á÷ µî¿¡ Á¸ÀçÇÏ´Â Ç׿ø ¶Ç´Â Ç×ü¸¦ °ËÃâÇÏ´Â ¹æ¹ý. Ç×ü¸¦ Ç¥ÁöÇÏ´Â °æ¿ì¿¡´Â ´ë°³ Çü±¤ Ç×ü¹ýÀ̶ó°í ºÎ¸¥´Ù. Á÷Á¢¹ý°ú °£Á¢¹ýÀÇ 2°¡Áö ¹æ¹ýÀÌ Àִµ¥, Çü±¤ Ç×üÀÇ °æ¿ì¸¦ ¸»Çϸé Á÷Á¢¹ýÀº Á¶Á÷ ¼Ó¿¡ Á¸ÀçÇÏ´Â Ç׿ø¿¡ ´ëÇÏ¿© ƯÀÌÇÏ°Ô °áÇÕÇÏ´Â Çü±¤ Ç¥Áö Ç×ü¸¦ ¾ãÀº Á¶Á÷ ÀýÆí¿¡ ¹ÝÀÀ½Ã۰í, ±× ÀýÆíÀ» Àß ¾Ä¾î¼­ Çü±¤Çö¹Ì°æÀ¸·Î °üÂûÇϸé Á¶Á÷ ¼ÓÀÇ Ç׿ø°ú °áÇÕÇÑ Çü±¤ Ç×ü°¡ Çü±¤À» ¹ßÇϹǷΠ±× Ç׿øÀÇ Á¸À縦 ¾Ë ¼ö ÀÖ´Ù. °£Á¢¹ýÀº ¸ÕÀú Á¶Á÷ ÀýÆí ¼ÓÀÇ Ç׿ø°ú ÀÌ¿¡ ´ëÀÀÇÏ´Â ¹«Ç¥Áö Ç×ü¸¦ ¹ÝÀÀ½ÃŲ ÈÄ¿¡ ¾Ä°í, ¹«Ç¥Áö Ç×ü¿Í ƯÀÌÇÏ°Ô ¹ÝÀÀÇϴ ǥÁö Ç×ü¸¦ ¹ÝÀÀ½ÃÄѼ­ ¾ÄÀº ´ÙÀ½ Çü±¤Çö¹Ì°æÀ¸·Î °üÂûÇÏ¿© Ç׿øÀÇ Á¸À縦 °£Á¢ÀûÀ¸·Î °ËÃâÇÏ´Â ¹æ¹ýÀ¸·Î¼­ Á÷Á¢¹ý¿¡ ºñÇØ Çü±¤·®ÀÌ Áõ´ëÇϹǷΠ°ËÃâ¿¡ ¿ëÀÌÇÏ´Ù.
  • indirect method
    °£Á¢¹ý
    䵿ÇÑ Àλ󿡼­ Á¦ÀÛµÈ ¸ðÇü»ó¿¡¼­ Ä¡°ü ¼öº¹¹°À» Á¦ÀÛÇÏ´Â ¹æ¹ý.
  • indirect-direct method inlay
    Á÷Á¢ °£Á¢¹ý Àη¹ÀÌ
    Á÷Á¢¹ý°ú °£Á¢¹ýÀ» º´¿ëÇÏ¿© ¸¸µç Àη¹ÀÌ.
  • injection molding method
    »çÃâ ¼ºÇü¹ý
  • Kaiserling's method
    Ä«ÀÌÁ¦¸¦¸µ ÀúÀå¹ý
    Ç¥º»À» Æ÷¸£¸»¸° 40cc, ¹° 2,000cc, Áú»êÄ®·ý 30g, ÃÊ»ê Ä®·ý 60g,ÀÇ ¿ë¾×¿¡ 14Àϰ£ °íÁ¤ÇÑ´Ù. Ç¥º»ÀÇ »öÁ¶¸¦ Àç»ý½Ã۱â À§ÇÏ¿© 10-60ºÐ°£ 80% ¿¡Æ¿ ¾ËÄڿÿ¡ ´ã±Ù´Ù. º¸Á¸ ¾×¿¡´Â ±Û¸®¼¼¸° 500cc, 1% ¾Æºñ»ê 200cc, ¹° 2300cc, ÃÊ»ê Ä®·ý 250g, Ƽ¸ô 2.5g¸¦ È¥ÇÕÇÑ´Ù
  • label method
    øÆ÷ ¹æ¹ý
    µ¿ÀǾî=
  • Laewen's method
    ·¹º¥ ¹ý
    ½½ °üÀý Ãà³óÁõÀÇ ¹è³ó ¿ä¹ý.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
vinblastine sulfate A dimeric alkaloid obtained from Vinca rosea. It arrests mitosis in metaphase (although vincristine is more active in this respect) and exhibits greater antimetabolic activity than does vincristine; used in the treatment of Hodgkin's disease, choriocarcinoma, acute and chronic leukaemias, and other neoplastic diseases; blocks microtubule assembly.
Synonym: vincaleucoblastine.
(05 Mar 2000)
vincristine sulfate A dimeric alkaloid obtained from Vinca rosea; its antineoplastic activity is similar to that of vinblastine, but no cross-resistance develops between these two agents, and it is more useful than vinblastine in lymphocytic lymphosarcoma and acute leukaemia.
Synonym: leurocristine.
(05 Mar 2000)
metaproterenol sulfate 3,5-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol sulfate;a sympathomimetic bronchodilator used for the treatment of bronchial asthma and in chronic obstructive lung disease. It has relatively greater effect on b2-adrenergic receptors than b1, conferring some selectivity in relaxing bronchiolar smooth muscle as compared with cardiac stimulation.
Synonym: orciprenaline sulfate.
(05 Mar 2000)
guanacline sulfate Cyclazenin sulfate; [2-(3,6-Dihydro-4-methyl-1(2H)-pyridinyl)ethyl]guanidine sulfate dihydrate;an antihypertensive.
(05 Mar 2000)
guanadrel sulfate (1,4-Dioxaspiro[4,5]dec-2-ylmethyl)guanidine sulfate;an antihypertensive drug similar in action to guanethidine.
(05 Mar 2000)
guanethidine sulfate [2-(Octahydro-1-azocinyl)ethyl]guanidine sulfate;a potent antihypertensive agent. It appears to interfere with the release of the chemical mediator (norepinephrine) at the sympathetic neuroeffector junction; it does not produce ganglionic or parasympathetic blockade with recommended doses. In ophthalmology, it is used topically for the treatment of glaucoma and to counteract eyelid retraction in Graves' disease.
(05 Mar 2000)
guanochlor sulfate [2-(2,6-Dichlorophenoxy)ethyl]aminoguanidine sulfate;used as an alpha-adrenergic blocking agent for the treatment of essential hypertension
guanoxan sulfate (1,4-Benzodioxan-2-ylmethyl)guanidine sulfate;an antihypertensive agent.
(05 Mar 2000)
chondroitin sulfate B <chemical> Dermatan, 4-(hydrogen sulfate). A glycosaminoglycan found mostly in the skin but also in blood vessels, tendons, heart valves, and pulmonary connective tissue.
Chemical name: Dermatan, 4-(hydrogen sulfate)
(12 Dec 1998)
chondroitin sulfate C Chondroitin with sulfuric residues esterifying the 6-hydroxyl groups of the galactosamine residues.
(05 Mar 2000)
phenelzine sulfate (2-Phenethyl) hydrazine sulfate;a monoamine oxidase inhibitor used as an antidepressant.
(05 Mar 2000)
codeine sulfate A water-soluble salt of codeine, often used in solid pharmaceutical dosage forms. Also used in cough preparations, where the drug suppresses the cough reflex.
(05 Mar 2000)
piperazine estrone sulfate A purified preparation of natural estrone sulfate; the piperazine acts as a buffer to increase the stability of estrone sulfate.
(05 Mar 2000)
morphine sulfate Morphine used for formulation of tablets as well as solutions for parenteral, epidural, or intrathecal injection to relieve pain.
(05 Mar 2000)
polymyxin B sulfate An antibacterial effective in tularaemia, brucellosis, Pseudomonas infections, and urinary tract infections, but used systemically only for severe infections not responsive to less toxic agents; it is also used locally. Polymyxin B is a mixture of polymyxin B1 and polymyxin B2.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á